Boston Scientific Corporation

BSX's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

BSX Growth rates comparisons

Looking into Boston Scientific growth rates, revenue grew by 9.96 % in I. Quarter 2022 from the same quarter a year ago. Ranking at No. 1936

Medical Equipment & Supplies industry recorded growth of revenues by 7.5 %

Boston Scientific's net profit deacreased by -67.74 % in I. Quarter 2022 year on year, to $110 millions.

• More on BSX's Growth

BSX's Valuation comparisons

Boston Scientific
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Boston Scientific PEG ratio is at 0.25 Boston Scientific realized cash outflow of $ -1.2per share in trailing twelve-month period.

Company

72.23

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 4.5.
Medical Equipment & Supplies industry's Price to Sales ratio is at 31.88.

• More on BSX's Valuation

Total Debt (Millions $)	9,305
Dividend TTM ($)	0.04 $
Dividend Yield TTM (%)	0.11 %
Revenue/Employee (TTM) $	337,833
Net Income/Employee (TTM) $	22,500
Receivable Turnover (TTM)	6.96
Tangible Book Value (Per Share $)	-1.94

BSX's Valuation comparisons

Company

72.23

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 4.5.
Medical Equipment & Supplies industry's Price to Sales ratio is at 31.88.

Boston Scientific Price to Book Ratio is at 3.27 lower than Indusry Avg. of 3804.08. and higher than S&P 500 Avg. of -0.01

• More on BSX's Valuation

• Market Capitalization (Millions $)	54,688
• Shares Outstanding (Millions)	1,438
• Employees	36,000
• Revenues (TTM) (Millions $)	12,162
• Net Income (TTM) (Millions $)	810
• Cash Flow (TTM) (Millions $)	-1,724
• Capital Exp. (TTM) (Millions $)	-600
• Total Debt (Millions $)	9,305
• Dividend TTM ($)	0.04 $
• Dividend Yield TTM (%)	0.11 %
• Revenue/Employee (TTM) $	337,833
• Net Income/Employee(TTM) $	22,500
• Receivable Turnover Ratio (TTM)	6.96
• Tangible Book Value (Per Share $)	-1.94

• Market Capitalization (Millions $)	54,688
• Shares Outstanding (Millions)	1,438
• Employees	36,000
• Revenues (TTM) (Millions $)	12,162
• Net Income (TTM) (Millions $)	810
• Cash Flow (TTM) (Millions $)	-1,724
• Capital Exp. (TTM) (Millions $)	-600

BSX's Profitability Comparisons

Boston Scientific achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2022 to 15.4 % from 5.76 % in IV. Quarter.

Boston Scientific net profit margin of 3.64 % is currently ranking no. 43 in Medical Equipment & Supplies industry, ranking no. 156 in Healthcare sector and number 2143 in S&P 500.

Profitability by Segment

	*Ratio*
• Capital Ratio (MRQ)	1.18
• Total Debt to Equity (MRQ)	0.56
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.38
• Inventory Turnover Ratio (TTM)	2.37

BSX's Profitability Comparisons

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar SOBR's Profile Stock Price SOBR's Financials Business Description Fundamentals Charts & Quotes SOBR's News Suppliers SOBR's Competitors Customers & Markets Economic Indicators SOBR's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Industries

At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets

At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071